What is the Amanta Healthcare IPO date & price?
- Answer Field
-
The IPO date and price are TBA, with details expected to be released soon.
BAJAJ BROKING
Amanta Healthcare Limited is a prominent player in the healthcare industry, specializing in the manufacturing of intravenous (IV) solutions and sterile liquid injectables. The company has established itself as a leader in the field of parenteral drug manufacturing, offering a wide range of products that cater to both domestic and international markets. Its advanced manufacturing capabilities and adherence to high-quality standards have enabled Amanta Healthcare to gain a strong foothold in the market.
Core Business and Market Position
The company’s core business revolves around producing high-quality IV solutions, which are essential in healthcare settings for patients requiring fluid administration and medication delivery. Amanta Healthcare has built a solid reputation due to its cutting-edge technology and stringent quality control measures. This has allowed the company to expand its product portfolio and strengthen its market position both in India and globally.
The Amanta Healthcare IPO aims to raise capital for business expansion and meet corporate objectives. The funds will be utilized to enhance the company's manufacturing capabilities, reduce debt, and invest in research and development to foster innovation. Below is a detailed breakdown:
Detail | Information |
Issue Type | Book-Built |
Fresh Issue | Up to 1,25,00,000 equity shares |
Offer for Sale | Not Applicable |
Listing | BSE and NSE |
Registrar | Link Intime India Private Ltd. |
Purpose of the IPO
Event | Date |
IPO Open Date | TBA |
IPO Close Date | TBA |
Basis of Allotment | TBA |
Initiation of Refunds | TBA |
Credit of Shares to Demat | TBA |
Listing Date | TBA |
Cut-off time for UPI mandate confirmation | TBA |
Online Application Process
Step 1: Log in to your Bajaj Broking trading account linked to your Demat account.
Step 2: Navigate to the IPO section and select " Amanta Healthcare IPO."
Step 3: Choose the number of shares and the price within the specified range.
Step 4: Complete the UPI mandate or ASBA process to block the required funds.
Step 5: Submit your application.
Potential Risks of Investing in the IPO:
Opportunities and Growth Potential:
Registrar | Contact Information |
Link Intime India Private Ltd. | Email: amantahealthcare.ipo@linkintime.co.in |
Lead Manager | Contact Information |
Beeline Capital Advisors | Email: mb@beelinemb.com |
Amanta Healthcare’s IPO presents an opportunity for investors to engage with a company that is well-established in the healthcare industry. With a solid business model, continuous growth, and a clear vision for future expansion, it stands to gain traction in the market. However, investors should weigh the potential risks before making investment decisions.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Tata Communications Q2 Results FY24-25 Highlights
17 Oct, 2024 | 2 Min. read
Havells India Q2 Results FY24-25 Highlights, Revenue and Profit Surge
17 Oct, 2024 | 2 Min. read
Polycab Q2 Results FY24-25 Highlights
17 Oct, 2024 | 2 Min. read
Central Bank of India Q2 Results FY24-25 Highlights:
17 Oct, 2024 | 2 Min. read
Tata Chemicals Q2 Results FY24-25 Highlights
17 Oct, 2024 | 2 Min. read
Axis Bank Q2 Results FY24-25 Highlights
17 Oct, 2024 | 2 Min. read
Infosys Q2 Results FY24-25 Highlights
17 Oct, 2024 | 2 Min. read
Wipro Q2 Results FY24-25 Highlights: Net Income Up by 21.3% YoY, $1.5 Billion worth Large Deals
17 Oct, 2024 | 3 Min. read
Ceat Q2 Results FY24-25 Preview | Estimate
17 Oct, 2024 | 1 Min. read
Commodities Market Today | Crude Oil, Gold, and Silver Prices Edge Higher
17 Oct, 2024 | 1 Min. read
IRCON Signs MoU with Patel Engineering for Global Projects
17 Oct, 2024 | 2 Min. read
Share Market Today | Gift Nifty Indicates Flat Opening; Range 24,940-25,200
17 Oct, 2024 | 4 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
The IPO date and price are TBA, with details expected to be released soon.
Amanta Healthcare is a leading manufacturer of intravenous solutions. This IPO is significant as it will help the company fund expansion, reduce debt, and support innovation in the healthcare sector.
The price band is TBA and will be decided based on market demand and valuation, in consultation with the lead managers
To apply through your Bajaj Broking Demat Account, go to the IPO section, and select " Amanta Healthcare IPO." Choose quantity and price, complete the UPI mandate or ASBA process, and submit your application to block the required funds.
Key risks include market competition and regulatory challenges, while rewards stem from the company’s potential for growth in the expanding healthcare sector.
The shares will be listed on the NSE and BSE after the allotment process, with the listing date TBA.
Investors should review the Draft Red Herring Prospectus, financials, and risk factors outlined by the company.
The dividend policy will depend on the company’s profitability post-listing, and any such decisions are TBA.
No Result Found
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading